JAMA & ARCHIVES
Arch Fam Med
SEARCH
GO TO ADVANCED SEARCH
HOME  PAST ISSUES  TOPIC COLLECTIONS  CME  PHYSICIAN JOBS  CONTACT US  HELP
Institution: CLOCKSS  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 8 No. 3, May 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (15)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Hypertension
 •Alert me on articles by topic

Predictors and Mediators of Successful Long-term Withdrawal From Antihypertensive Medications

Mark A. Espeland, PhD; Paul K. Whelton, MD; John B. Kostis, MD; Judy L. Bahnson; Walter H. Ettinger, MD; Jeffrey A. Cutler, MD; Larry J. Appel, MD; Shiriki Kumanyika, PhD; Deborah Farmer, PhD; Jan Elam; Alan C. Wilson, PhD; William B. Applegate, MD; for the TONE Cooperative Research Group

Arch Fam Med. 1999;8:228-236.

Background  National guidelines recommend consideration of step down or withdrawal of medication in patients with well-controlled hypertension, but knowledge of factors that predict or mediate success in achieving this goal is limited.

Objective  To identify patient characteristics associated with success in controlling blood pressure (BP) after withdrawal of antihypertensive medication.

Design  The Trial of Nonpharmacologic Interventions in the Elderly tested whether lifestyle interventions designed to promote weight loss or a reduced intake of sodium, alone or in combination, provided satisfactory BP control among elderly patients (aged 60-80 years) with hypertension after withdrawal from antihypertensive drug therapy. Participants were observed for 15 to 36 months after attempted drug withdrawal.

Main Outcome Measures  Trial end points were defined by (1) a sustained BP of 150/90 mm Hg or higher, (2) a clinical cardiovascular event, or (3) a decision by participants or their personal physicians to resume BP medication.

Results  Proportional hazards regression analyses indicated that the hazard (±SE) of experiencing an end point among persons assigned to active interventions was 75%±9% (weight loss), 68%±7% (sodium reduction), and 55%±7% (combined weight loss/sodium reduction) that of the hazard for those assigned to usual care. Lower baseline systolic BP (P<.001), fewer years since diagnosis of hypertension (P<.001), fewer years of antihypertensive treatment (P<.001), and no history of cardiovascular disease (P=.01) were important predictors of maintaining successful nonpharmacological BP control throughout follow-up, based on logistic regression analysis. Age, ethnicity, baseline level of physical activity, baseline weight, medication class, smoking status, and alcohol intake were not statistically significant predictors. During follow-up, the extent of weight loss (P=.001) and urinary sodium excretion (P=.04) were associated with a reduction in the risk of trial end points in a graded fashion.

Conclusions  Withdrawal from antihypertensive medication is most likely to be successful in patients with well-controlled hypertension who have been recently (within 5 years) diagnosed or treated, and who adhere to lifestyle interventions involving weight loss and sodium reduction. More than 80% of these patients may have success in medication withdrawal for longer than 1 year.


From the Section on Biostatistics (Dr Espeland and Ms Bahnson) and the Department of Medicine (Drs Ettinger and Farmer), Wake Forest University School of Medicine, Winston-Salem, NC; Tulane University School of Public Health and Tropical Medicine, New Orleans, La (Dr Whelton); Department of Medicine, University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School, New Brunswick (Drs Kostis and Wilson); National Heart, Lung, and Blood Institute, Bethesda, Md (Dr Cutler); Welch Center for Prevention, Epidemiology, and Clinical Research, The Johns Hopkins University School of Hygiene and Public Health and School of Medicine, Baltimore, Md (Dr Appel); Department of Human Nutrition and Dietetics, University of Illinois at Chicago (Dr Kumanyika); Department of Medicine, University of Tennessee–Memphis (Ms Elam and Dr Applegate). A complete list of members of the TONE Cooperative Research Group was previously published (JAMA. 1998;279:839-846).


RELATED ARTICLE

The Archives of Family Medicine Continuing Medical Education Program
Arch Fam Med. 1999;8(3):207-209.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Age-Related Bias in the Management of Hypertension: A National Survey of Physicians' Opinions on Hypertension in Elderly Adults
Hajjar et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2002;57:M487-491.
ABSTRACT | FULL TEXT  

Effects of Reduced Sodium Intake on Hypertension Control in Older Individuals: Results From the Trial of Nonpharmacologic Interventions in the Elderly (TONE)
Appel et al.
Arch Intern Med 2001;161:685-693.
ABSTRACT | FULL TEXT  




HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.